Thyrocare Technologies

Thyrocare Technologies

1,350.60
+20.30
(1.53%)
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
Market Cap
7,049.90 Cr
EPS
17.13
PE Ratio
55.73
Dividend Yield
1.58 %
52 Week High
1,474.00
52 Week Low
658.00
PB Ratio
13.21
Debt to Equity
0.06
Analyst Rating and Forecast
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Docon Technologies Private Limited, a wholly owned subsidiary of API Holdings Limited and promoter of Thyrocare Technologies Limited, sold 53,32,860 equity shares representing approximately 10% of Thyrocare's total paid-up share capital. The transaction was completed on October 24, 2025 through market trades. Following this sale, Docon's promoter shareholding in Thyrocare decreased from 70.98% to 60.93% of the total paid-up equity share capital. Docon continues to remain a promoter and holding company of Thyrocare after the transaction. The disclosure was made under regulatory requirements to stock exchanges BSE Limited and National Stock Exchange of India Limited.
neutral
ICICI Prudential Mutual Fund acquired 19,98,400 shares of Thyrocare Technologies on October 24, 2025, through secondary market purchases. This acquisition increased the fund's total shareholding from 8,25,490 shares (1.56%) to 28,23,890 shares (5.33%) of the company's paid-up capital. The fund clarified that the holding is from an investment perspective and not aimed at seeking controlling interest. Thyrocare Technologies has a total equity share capital of ₹52,99,44,470 comprising 5,29,94,447 shares with a face value of ₹10 each. The company's shares are listed on BSE Limited and National Stock Exchange of India Limited.
neutral
Docon Technologies Private Limited, a promoter of Thyrocare Technologies Limited, sold 53,32,860 equity shares representing approximately 10% of the company's total paid-up capital through market trades on October 24, 2025. The transaction was executed at an average price of Rs 1,252.03 per share for a total consideration of Rs 667.69 crore. Following this sale, Docon remains a promoter of the company, with the overall promoter shareholding decreasing from 70.98% to 60.93%.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,089.60
#1 25,900.90
49.89
#1 2,554.80
11.28
#1 492
24.30
44.69
1,007.15
10,271.50
68.07
699.70
23.06
144
22.54
50.32
1,944.80
10,071.90
66.10
1,346.30
10.64
146
18.90
42.56
1,350.60
#4 7,049.90
#7 55.73
#5 702.20
#4 20.80
#4 91
#2 81.06
66.95
791.30
2,581.00
32.23
742.70
16.70
78
14.53
44.40
323.00
1,681.40
51.54
255.90
15.11
31
19.48
66.94
1,374.00
1,137.40
23.19
111.60
28.72
48
11.50
46.91
302.05
954.00
#1 -6.43
1,170.80
-18.47
-134
-35.12
46.90
360.00
672.80
25.33
147.80
#1 134.60
19
#1 444.44
68.63
145.10
99.80
66.94
41.80
13.28
2
0.00
26.71

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
20.80 %
Net Income Growth
30.65 %
Cash Flow Change
14.13 %
ROE
25.97 %
ROCE
43.70 %
EBITDA Margin (Avg.)
15.68 %

Quarterly Financial Results

Quarterly Financials
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
56
63
55
67
72
81
74
89
93
92
88
108
99
107
100
108
112
119
107
104
58
158
141
151
175
191
119
133
129
137
131
140
136
151
138
158
161
180
170
192
198
220
Expenses
37
36
35
41
42
64
51
60
53
53
49
60
56
61
61
71
64
64
62
77
48
91
89
95
94
87
81
93
92
103
100
111
100
111
103
121
115
129
124
130
135
145
EBITDA
20
26
20
27
30
17
23
30
39
39
39
48
43
46
39
37
48
55
45
26
9
67
52
55
81
104
38
40
37
33
31
29
36
40
35
37
46
51
46
62
63
75
Operating Profit %
34 %
39 %
36 %
38 %
39 %
18 %
28 %
32 %
39 %
40 %
42 %
39 %
42 %
41 %
37 %
33 %
42 %
45 %
41 %
24 %
15 %
40 %
36 %
35 %
43 %
51 %
31 %
29 %
28 %
23 %
22 %
18 %
26 %
25 %
23 %
22 %
27 %
27 %
25 %
30 %
30 %
33 %
Depreciation
5
4
5
5
4
4
5
5
4
5
5
6
6
7
7
7
7
8
8
9
7
8
8
8
7
8
9
10
9
9
10
11
10
11
14
13
11
13
17
14
11
12
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
-0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Profit Before Tax
17
25
19
22
26
13
19
25
35
34
34
42
38
39
32
29
40
46
37
18
2
59
44
48
74
95
29
30
28
24
20
17
25
28
20
23
34
37
28
47
51
63
Tax
6
9
8
8
9
11
9
9
13
10
12
17
14
14
12
13
13
11
9
19
2
16
12
10
18
18
7
9
6
8
5
5
8
8
5
6
10
10
9
26
12
15
Net Profit
11
16
11
14
17
1
9
15
22
25
22
25
23
25
20
16
28
35
28
-2
0
43
32
38
56
78
22
21
22
15
15
13
17
20
15
17
24
26
19
22
38
48
EPS in ₹
2.33
3.28
2.13
2.71
3.18
0.22
1.71
2.90
4.10
4.59
4.03
4.68
4.35
4.70
3.81
3.09
5.20
6.73
5.21
-0.30
0.04
8.15
6.13
7.14
10.51
14.70
4.05
4.04
4.11
3.80
2.78
2.36
3.26
3.84
2.78
3.54
4.52
4.99
3.58
4.17
7.35
9.05

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
329
410
438
479
475
471
546
608
633
644
693
Fixed Assets
196
259
259
299
294
269
253
285
294
306
297
Current Assets
111
134
150
142
136
152
240
270
273
279
338
Capital Work in Progress
6
1
17
0
2
5
8
3
2
3
14
Investments
84
92
104
120
95
90
126
146
144
162
162
Other Assets
43
58
58
60
84
107
159
174
193
173
220
Total Liabilities
329
410
438
479
475
471
546
608
633
644
693
Current Liabilities
7
31
18
20
21
82
95
65
77
91
122
Non Current Liabilities
10
13
12
15
19
23
23
17
20
26
24
Total Equity
312
366
408
443
435
367
427
527
535
528
547
Reserve & Surplus
226
312
354
390
382
314
374
474
463
440
439
Share Capital
51
54
54
54
53
53
53
53
53
53
53

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-6
5
-1
-0
-5
4
5
0
4
-9
8
Investing Activities
-18
-18
-42
-43
-12
1
-49
-24
-39
-91
-53
Operating Activities
35
68
90
107
100
168
115
113
129
168
191
Financing Activities
-23
-45
-49
-64
-94
-165
-62
-89
-86
-85
-130

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
66.14 %
66.14 %
71.22 %
71.18 %
71.18 %
71.18 %
71.14 %
71.14 %
71.14 %
71.14 %
71.14 %
71.11 %
71.11 %
71.11 %
71.11 %
71.06 %
71.06 %
71.06 %
71.06 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
3.46 %
0.00 %
2.90 %
2.49 %
1.93 %
2.77 %
2.41 %
3.23 %
4.85 %
DIIs
7.14 %
6.17 %
6.07 %
6.37 %
6.52 %
6.68 %
8.66 %
8.69 %
8.45 %
13.46 %
13.33 %
13.55 %
14.88 %
14.90 %
14.80 %
14.67 %
14.97 %
14.54 %
13.47 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
5.01 %
6.32 %
7.60 %
7.44 %
6.65 %
6.71 %
7.28 %
8.07 %
8.38 %
9.42 %
9.66 %
9.15 %
8.48 %
8.66 %
9.78 %
9.16 %
9.21 %
8.94 %
8.19 %
Others
21.71 %
21.37 %
15.11 %
15.01 %
15.66 %
15.43 %
12.91 %
12.10 %
12.03 %
5.97 %
2.42 %
6.19 %
2.63 %
2.84 %
2.38 %
2.33 %
2.36 %
2.23 %
2.43 %
No of Share Holders
0
44,722
53,140
62,936
65,769
66,315
66,431
71,412
74,386
76,292
72,000
68,844
64,823
61,636
59,377
56,666
57,403
54,566
54,142

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 10 10 20 5 25 15 18 18 21
Dividend Yield (%) 0.00 1.68 1.87 4.03 0.55 3.22 3.56 3.05 2.65 1.58

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
19 Jun 2021 DIVIDEND Dividend
₹ 15.00 /share
17 Jun 2021 1,059.45 1,287.65
12 May 2022 DIVIDEND Dividend
₹ 15.00 /share
11 May 2022 812.25 736.75
20 Apr 2023 DIVIDEND Dividend
₹ 18.00 /share
20 Apr 2023 446.85 504.70
16 Aug 2024 DIVIDEND Dividend
₹ 18.00 /share
16 Aug 2024 619.25 879.70
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 818.05 892.80
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 828.55 886.45
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 827.90 806.35
23 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Apr 2025 701.65 794.30
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jul 2025 1,164.70 1,186.65
25 Jul 2025 DIVIDEND Dividend
₹ 21.00 /share
25 Jul 2025 794.30 1,338.30
31 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Jul 2025 1,020.40 1,299.60
14 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Oct 2025 1,179.30 1,263.10
24 Oct 2025 DIVIDEND Dividend
₹ 7.00 /share
24 Oct 2025 1,263.10 1,251.90

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20111 day ago
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 20112 days ago
Disclosure Of Sale Of 5332860 Equity Shares (Approximately 10% Stake) By Promoter - Docon Technologies Private Limited5 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptOct 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 17, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 16, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 14, 2025
Corporate Action-Board recommends Bonus IssueOct 14, 2025
Record Date For Purpose Of Interim DividendOct 14, 2025
Corporate Action-Board approves DividendOct 14, 2025
Re-Appointment Of Internal AuditorOct 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 14, 2025
Financial Results For The Quarter And Half Year Ended September 30 2025.Oct 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On October 14 2025Oct 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 06, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 Declaration Of Interim Dividend And Proposal For Issue Of Bonus Shares.Oct 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotSep 26, 2025
Closure of Trading WindowSep 26, 2025
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Sep 24, 2025
Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.Sep 23, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 19, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 18, 2025
Disclosure under Regulation 30A of LODRSep 15, 2025
Disclosure under Regulation 30A of LODRSep 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotAug 25, 2025
Thyrocare Technologies Limited Has Informed The Exchange About Intimation Regarding The Appointment Of Mr. Rahul Guha As Managing Director And Chief Executive Officer Of API Holdings Limited Ultimate Holding Company In Addition To His Current Position Of Aug 06, 2025
Intimation Regarding The Appointment Of Mr. Rahul Guha Managing Director And Chief Executive Officer Of The Company As Managing Director And Chief Executive Officer Of API Holdings Limited Ultimate Holding CompanyAug 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 31, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 31, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 28, 2025
General UpdateJul 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Audio Recordings Of Earnings Conference Call For The Quarter Ended June 30 2025. Jul 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jul 23, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jul 23, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJul 23, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Nippon India Pharma Fund Direct-Growth
2.25%
-161005
-0.38%
-0.38%
Nippon India Small Cap Fund Direct- Growth
0.30%
-152623
-0.07%
-0.08%
ICICI Prudential India Opportunities Fund Direct - Growth
0.14%
-59802
-0.04%
-0.05%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.23%
52297
0.23%
0.23%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
1.19%
-30750
-1.09%
-1.18%
Aditya Birla Sun Life Bal Bhavishya Yojna Direct-Growth
1.51%
27033
0.15%
0.70%
Shriram Multi Sector Rotation Fund Direct-Growth
1.82%
-22232
-1.75%
-1.75%
ICICI Prudential Exports and Services Fund Direct-Growth
0.17%
20320
0.17%
0.17%
ICICI Prudential Active Momentum Fund Direct-Growth
0.14%
15583
0.14%
0.14%
DSP India T.I.G.E.R. (The Infrastructure Growth and Economic Reforms Fund) Direct-Growth
0.44%
-15000
-0.08%
-0.58%
ICICI Prudential Dividend Yield Equity Fund Direct-Growth
0.02%
12100
0.02%
0.02%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
1.93%
6300
-0.04%
0.11%
Shriram Flexi Cap Fund Direct - Growth
0.00%
-5100
-0.48%
0.00%
Shriram ELSS Tax Saver Fund Direct - Growth
0.00%
-1800
-0.48%
0.00%
Groww Nifty Total Market Index Fund Direct - Growth
0.01%
248
0.01%
0.01%
Angel One Nifty Total Market Index Fund Direct - Growth
0.01%
37
0.01%
0.01%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.01%
34
0.01%
0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.01%
31
0.01%
0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.14%
-7
-0.01%
-0.01%
DSP Equity Savings Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Pharma And Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%
Quant ESG Integration Strategy Fund Direct - Growth
0.00%
0
0.00%
0.00%
Quant Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%
Quant Small Cap Fund Direct Plan-Growth
0.41%
0
-0.05%
-0.06%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1.39%
0
-0.14%
-0.23%

Technical Indicators

RSI(14)
Neutral
64.57
ATR(14)
Volatile
56.01
STOCH(9,6)
Neutral
26.08
STOCH RSI(14)
Overbought
92.90
MACD(12,26)
Bullish
10.19
ADX(14)
Strong Trend
36.30
UO(9)
Bearish
46.47
ROC(12)
Uptrend And Accelerating
10.25
WillR(14)
Neutral
-51.51